FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Beryl Drugs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524606 P/E (TTM) :47.78
ISIN Demat:INE415H01017 Div & Yield %:0 EPS (TTM) :0.46
Book Value (RS) :18.6259045 Market Cap (Rs Cr.):11.15 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.500.570.640.680.67
Long Term Debt-Equity Ratio0.220.300.290.240.28
Current Ratio1.901.691.411.231.16
Fixed Assets1.672.332.571.421.36
Inventory13.3923.1413.345.568.22
Debtors3.243.694.743.253.53
Interest Cover Ratio2.613.153.11-1.070.79
PBIDTM (%)12.5310.038.444.1111.64
PBITM (%)6.625.545.43-3.362.63
PBDTM (%)9.988.276.690.968.30
CPM (%)8.657.375.882.958.30
APATM (%)2.742.882.86-4.52-0.71
ROCE (%)9.9310.8011.25-3.722.79
RONW (%)6.309.0710.03-8.67-1.29

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)